Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_assertion type Assertion NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_head.
- NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_assertion description "[GEP NETs occur either sporadically or as part of endocrine tumor susceptibility syndromes such as multiple endocrine neoplasia type 1 (MEN1), von Hippel Lindau (VHL) syndrome, neurofibromatosis (NF-1), and possibly tuberous sclerosis (TSC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_provenance.
- NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_assertion evidence source_evidence_literature NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_provenance.
- NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_assertion SIO_000772 19125015 NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_provenance.
- NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_assertion wasDerivedFrom befree-20140225 NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_provenance.
- NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_assertion wasGeneratedBy ECO_0000203 NP929830.RAbUvfdQ9ObWI4k-8vEFwu20E1jnzSME6lmFu3B1Nj7kI130_provenance.